Zuckerman Investment Group’s Teva Pharmaceuticals TEVA Stock Holding History

Zuckerman Investment Group’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-36,406	Closed	-$735K	–	165
2025 Q3	$735K	Hold	36,406	–	–	0.07%	95
2025 Q2	$610K	Hold	36,406	–	–	0.06%	99
2025 Q1	$560K	Hold	36,406	–	–	0.06%	107
2024 Q4	$632K	Buy	36,406 +5,000	+16%	+$91K	0.06%	99
2024 Q3	$566K	Hold	31,406	–	–	0.06%	99
2024 Q2	$510K	Sell	31,406 -10,000	-24%	-$154K	0.06%	96
2024 Q1	$584K	Buy	+41,406	New	+$522K	0.07%	88
2023 Q1	–	Sell	-56,406	Closed	-$514K	–	133
2022 Q4	$514K	Buy	+56,406	New	+$492K	0.08%	81
2022 Q3	–	Sell	-20,000	Closed	-$150K	–	123
2022 Q2	$150K	Hold	20,000	–	–	0.03%	104
2022 Q1	$188K	Buy	+20,000	New	+$167K	0.03%	105
2021 Q2	–	Sell	-21,406	Closed	-$247K	–	118
2021 Q1	$247K	Hold	21,406	–	–	0.04%	98
2020 Q4	$207K	Hold	21,406	–	–	0.04%	84
2020 Q3	$193K	Hold	21,406	–	–	0.04%	75
2020 Q2	$264K	Hold	21,406	–	–	0.06%	68
2020 Q1	$192K	Buy	+21,406	New	+$219K	0.06%	66
2019 Q4	–	Sell	-10,406	Closed	-$72K	–	71
2019 Q3	$72K	Hold	10,406	–	–	0.02%	65
2019 Q2	$96K	Buy	+10,406	New	+$125K	0.02%	64

Other funds holding TEVA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Zuckerman Investment Group's TEVA Position: Q4 2025 in Review

Zuckerman Investment Group sold out of Teva Pharmaceuticals (TEVA) in Q4 2025, closing a stake of 36,406 shares — an estimated $735K sold.

Zuckerman Investment Group first reported a position in TEVA in Q2 2019 and held it in 17 quarters. The position peaked at $735K in Q3 2025. 629 funds tracked by Wall St. Rank hold TEVA as of Q4 2025.

Zuckerman Investment Group reported no remaining Teva Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
Zuckerman Investment Group sold 36,406 Teva Pharmaceuticals shares in Q4 2025, an estimated $735K.
Zuckerman Investment Group first reported a position in Teva Pharmaceuticals in Q2 2019 and held it in 17 quarters.
Zuckerman Investment Group's Teva Pharmaceuticals position peaked at $735K in Q3 2025.
629 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2025.

Based on Zuckerman Investment Group's 13F filing for Q4 2025, filed 13 Feb 2026.